DENDREON CORP
DelistedCIK 1107332fmd_12Y2D1C6VT8V1VC272VJPK4CGFManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2014, 23 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 48 | 342 | 326 | 284 |
| Cost of revenue | – | – | 29 | 159 | 228 | 166 |
| Gross profit | 0 | 0 | 20 | 183 | 98 | 117 |
| Research and development | 50 | 62 | 76 | 74 | 75 | 71 |
| Selling, general and administrative | – | 39 | 236 | 361 | 317 | 233 |
| Total operating expenses | 71 | 100 | 340 | 633 | 665 | 527 |
| Operating income | (70) | (100) | (292) | (292) | (340) | (243) |
| Interest expense | 5 | 2 | 2 | 48 | 55 | 54 |
| Interest and investment income | 4 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income (expense) | – | – | – | 0 | 0 | (0) |
| Income before taxes | (72) | (220) | (440) | (338) | (394) | – |
| Income tax expense | – | – | (0) | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (439) | (338) | (394) | – |
| Net income | (72) | (220) | (439) | (338) | (394) | (297) |